PFIC Space Hots Up With Albireo and Mirum Filings
Promising Therapies For Rare Liver Disease
Patients with the rare condition progressive familial intrahepatic cholestasis (PFIC) look set to have two possible therapeutic choices if recent filings for two IBAT inhibitors are successful.
